Skip to main content
Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5256
-0.0002 (-0.04%)
Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Dec '24 Dec '23 Dec '22
Allogeneic Cell Therapies
6.59M
Log In
Log In
Allogeneic Cell Therapies Growth
194.81%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Dec '24 Dec '23 Dec '22
United States
6.59M
Log In
Log In
United States Growth
194.81%
Log In
Log In